The Generics Bulletin Top 50, Part One: Top Ten Ranking Conceals Changes For Industry Leaders
Only Minor Changes To List Of Top Players This Year, Despite Upheaval For Leading Firms
A deceptively familiar top 10 of generics and biosimilars industry leaders this year belies the significant evolutions seen for major off-patent players over the past 12 months. We reveal the changes under the surface in the first instalment of this year’s Generics Bulletin Top 50.
